AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

subbarao kantaDr. Subbarao’s research is focused on newly emerging viral diseases of global importance: pandemic influenza and the severe acute respiratory syndrome (SARS). The goal of the research program is to develop vaccines; this bench-to-clinic program includes investigations that range from pathogenesis to applied vaccinology. The influenza program addresses questions of viral antigenicity including evaluation of genetic and antigenic relatedness and cross-protection between animal influenza viruses, pathogenesis, host responses, and vaccine development. Pathogenesis and host responses to vaccines and immunoprophylaxis strategies are evaluated in animal models. Preclinical and clinical evaluations are undertaken for vaccines generated from viruses with site-specific mutations generated by plasmid-based reverse genetics.

TPL_asm2013_SEARCH

91148